HTG Molecular Diagnostics Hosting a KOL Event Addressing Drug Candidate Attrition

TUCSON, Ariz. , July 19, 2022 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will host a key opinion leader (KOL) webinar on “ Drug